Niklas von Spreckelsen

Dr. Niklas von Spreckelsen

University Hospital Cologne, Cologne, North Rhine-Westphalia, Germany
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
THTodd Hollon
Todd Hollon
CJCheng Jiang
Cheng Jiang
ACAsadur Chowdury
Asadur Chowdury
MNMustafa Nasir-Moin
Mustafa Nasir-Moin
AKAkhil Kondepudi
Akhil Kondepudi
DODaniel A. Orringer
Daniel A. Orringer

5 June 2020 in Molecular Cell
Verified
Journal Article
Closed access
MMMarco Mineo
Marco Mineo
SLShawn M. Lyons
Shawn M. Lyons
MZMykola Zdioruk
Mykola Zdioruk
NSNiklas von Spreckelsen
Niklas von Spreckelsen
RFRuben Ferrer-Luna
Ruben Ferrer-Luna
ACAntonio Chiocca
Antonio Chiocca

21 May 2018 in Journal of International Medical Research
Verified
Journal Article
Open access
FZFeng Zheng
Feng Zheng
HXHao Xu
Hao Xu
NSNiklas von Spreckelsen
Niklas von Spreckelsen
PSPantelis Stavrinou
Pantelis Stavrinou
MTMarco Timmer
Marco Timmer
BKBoris Krischek
Boris Krischek
Objective: To evaluate the effectiveness of early (3 months) on post-operative complications in patients receiving decompressive craniotomy (DC) for traumatic brain injury (TBI). Methods: The Cochrane Library, PubMed and EMBASE databases were systematically searched for studies published prior to May 21, 2017. A meta-analysis examined post-operative overall complication rates, infection rates, subdural fluid collection and operating times according to early and late CP. Results: Of the initial 1675 references, five studies, all cohort, involving a total of 413 patients, were selected for the review. There was no difference between early and late CP in post-operative overall complication rate (RR=0.68, 95%CI [0.36, 1.29]) and the post-operative infection rate (RR=0.50, 95%CI [0.20, 1.24]) in patients receiving DC for TBI. However, there was a significant difference in post-operative subdural effusion (RR=0.24, 95%CI [0.07, 0.78]) and mean operative time (mean difference = −33.02 min, 95%CI [−48.19, −17.84]) both in favour of early CP. Conclusions: No differences were found between early and late CP in post-operative overall complications and procedural related infections in patients receiving DC for TBI, but early CP reduced the complication of subdural effusion and the mean operating time. These findings need to be confirmed by large, randomised controlled trials.

6 August 2022 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
DRDavid Reinecke
David Reinecke
NSNiklas von Spreckelsen
Niklas von Spreckelsen
CMChristian Mawrin
Christian Mawrin
AIAdrian Ion-Margineanu
Adrian Ion-Margineanu
GFGina Fürtjes
Gina Fürtjes
VNVolker Neuschmelting
Volker Neuschmelting
Determining the presence of tumor in biopsies and the decision-making during resections is often dependent on intraoperative rapid frozen-section histopathology. Recently, stimulated Raman scattering microscopy has been introduced to rapidly generate digital hematoxylin-and-eosin-stained-like images (stimulated Raman histology) for intraoperative analysis. To enable intraoperative prediction of tumor presence, we aimed to develop a new deep residual convolutional neural network in an automated pipeline and tested its validity. In a monocentric prospective clinical study with 94 patients undergoing biopsy, brain or spinal tumor resection, Stimulated Raman histology images of intraoperative tissue samples were obtained using a fiber-laser-based stimulated Raman scattering microscope. A residual network was established and trained in ResNetV50 to predict three classes for each image: (1) tumor, (2) non-tumor, and (3) low-quality. The residual network was validated on images obtained in three small random areas within the tissue samples and were blindly independently reviewed by a neuropathologist as ground truth. 402 images derived from 132 tissue samples were analyzed representing the entire spectrum of neurooncological surgery. The automated workflow took in a mean of 240 s per case, and the residual network correctly classified tumor (305/326), non-tumorous tissue (49/67), and low-quality (6/9) images with an inter-rater agreement of 89.6% (κ = 0.671). An excellent internal consistency was found among the random areas with 90.2% (Cα = 0.942) accuracy. In conclusion, the novel stimulated Raman histology-based residual network can reliably detect the microscopic presence of tumor and differentiate from non-tumorous brain tissue in resection and biopsy samples within 4 min and may pave a promising way for an alternative rapid intraoperative histopathological decision-making tool.

15 May 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CFColin M. Fadzen
Colin M. Fadzen
JWJustin M. Wolfe
Justin M. Wolfe
WZWen Zhou
Wen Zhou
CCChoi-Fong Cho
Choi-Fong Cho
NSNiklas von Spreckelsen
Niklas von Spreckelsen
BPBradley L. Pentelute
Bradley L. Pentelute

3 April 2020 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
NSNiklas von Spreckelsen
Niklas von Spreckelsen
NWNatalie Waldt
Natalie Waldt
RPRebecca Poetschke
Rebecca Poetschke
CKChristoph Kesseler
Christoph Kesseler
HDHildegard Dohmen
Hildegard Dohmen
CMChristian Mawrin
Christian Mawrin
Meningioma represents the most common primary brain tumor in adults. Recently several non-NF2 mutations in meningioma have been identified and correlated with certain pathological subtypes, locations and clinical observations. Alterations of cellular pathways due to these mutations, however, have largely remained elusive. Here we report that the Krueppel like factor 4 (KLF4)-K409Q mutation in skull base meningiomas triggers a distinct tumor phenotype. Transcriptomic analysis of 17 meningioma samples revealed that KLF4K409Q mutated tumors harbor an upregulation of hypoxia dependent pathways. Detailed in vitro investigation further showed that the KLF4K409Q mutation induces HIF-1α through the reduction of prolyl hydroxylase activity and causes an upregulation of downstream HIF-1α targets. Finally, we demonstrate that KLF4K409Q mutated tumors are susceptible to mTOR inhibition by Temsirolimus. Taken together, our data link the KLF4K409Q mediated upregulation of HIF pathways to the clinical and biological characteristics of these skull base meningiomas possibly opening new therapeutic avenues for this distinct meningioma subtype.